
GlobeStar Therapeutics Corporation – OTC:GSTC
GlobeStar Therapeutics stock price today
GlobeStar Therapeutics stock price monthly change
GlobeStar Therapeutics stock price quarterly change
GlobeStar Therapeutics stock price yearly change
GlobeStar Therapeutics key metrics
Market Cap | 6.31M |
Enterprise value | 5.02M |
P/E | -5.88 |
EV/Sales | N/A |
EV/EBITDA | -4.22 |
Price/Sales | N/A |
Price/Book | -4060.19 |
PEG ratio | -0.05 |
EPS | N/A |
Revenue | N/A |
EBITDA | -1.86M |
Income | -1.97M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeGlobeStar Therapeutics stock price history
GlobeStar Therapeutics stock forecast
GlobeStar Therapeutics financial statements
Mar 2023 | 0 | -166.59K | |
---|---|---|---|
Jun 2023 | 0 | -1.28M | |
Sep 2023 | 0 | -350.57K | |
Mar 2024 | 0 | -174.96K |
Payout ratio | 0% |
---|
2019 | 258.83% |
---|---|
2020 | |
2021 | |
2022 | |
2023 |
Mar 2023 | 176 | 1.29M | 733435.23% |
---|---|---|---|
Jun 2023 | 0 | 1.27M | Infinity% |
Sep 2023 | 0 | 1.43M | Infinity% |
Mar 2024 | 147708 | 1.61M | 1094.29% |
Mar 2023 | -53.74K | 0 | 46.2K |
---|---|---|---|
Jun 2023 | -40.17K | 0 | 40K |
Sep 2023 | -72.69K | 0 | 72.69K |
Mar 2024 | -12.38K | 0 | 12.38K |
GlobeStar Therapeutics other data
-
What's the price of GlobeStar Therapeutics stock today?
One share of GlobeStar Therapeutics stock can currently be purchased for approximately $0.
-
When is GlobeStar Therapeutics's next earnings date?
Unfortunately, GlobeStar Therapeutics's (GSTC) next earnings date is currently unknown.
-
Does GlobeStar Therapeutics pay dividends?
No, GlobeStar Therapeutics does not pay dividends.
-
How much money does GlobeStar Therapeutics make?
GlobeStar Therapeutics has a market capitalization of 6.31M.
-
What is GlobeStar Therapeutics's stock symbol?
GlobeStar Therapeutics Corporation is traded on the OTC under the ticker symbol "GSTC".
-
What is GlobeStar Therapeutics's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of GlobeStar Therapeutics?
Shares of GlobeStar Therapeutics can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When GlobeStar Therapeutics went public?
GlobeStar Therapeutics Corporation is publicly traded company for more then 6 years since IPO on 30 Nov 2018.
-
What is GlobeStar Therapeutics's official website?
The official website for GlobeStar Therapeutics is globestarthera.com.
-
Where are GlobeStar Therapeutics's headquarters?
GlobeStar Therapeutics is headquartered at 719 Jadewin Avenue, Richland, WA.
-
How can i contact GlobeStar Therapeutics?
GlobeStar Therapeutics's mailing address is 719 Jadewin Avenue, Richland, WA and company can be reached via phone at +20 64 511970.
GlobeStar Therapeutics company profile:

GlobeStar Therapeutics Corporation
globestarthera.comOTC
0
Biotechnology
Healthcare
GlobeStar Therapeutics Corporation, a clinical stage pharmaceutical company, focuses on developing a patented formulation of drugs for the treatment of multiple sclerosis and other neurodegenerative diseases. The company was formerly known as AngioSoma, Inc. and changed its name to GlobeStar Therapeutics Corporation in July 2021. The company was incorporated in 2016 and is headquartered in Richland, Washington.
Richland, WA 99352
CIK: 0001502152
:
: